Keyphrases
High-risk Human Papillomavirus (HR-HPV)
100%
People Living with HIV (PLHIV)
100%
Human Papillomavirus Genotypes
100%
CD4 T Cells
27%
HPV18
18%
Abortion History
18%
Cesarean Delivery
9%
Counseling
9%
Screening Rate
9%
Infection Rate
9%
Effective Approach
9%
Cervical Cancer
9%
Antiretroviral Therapy
9%
Demographic Factors
9%
Clinical Factors
9%
Mobile Phone
9%
Women Age
9%
Long-term Exposure
9%
High Prevalence
9%
HPV31
9%
Inverse Association
9%
Bamako
9%
HPV16
9%
GeneXpert
9%
Phone Contacts
9%
Self-sampling
9%
Marital Status
9%
History of Preeclampsia
9%
Sexual Debut
9%
High-risk Human Papillomavirus Infection
9%
History of Education
9%
Self-collected Sample
9%
Vaginal Self-sampling
9%
Nursing and Health Professions
Pilot Study
100%
Outpatient
100%
Prevalence
100%
Human Immunodeficiency Virus
100%
CD4 Lymphocyte Count
37%
Study Participant
25%
Uterine Cervix Cancer
12%
Hospital
12%
Preeclampsia
12%
Marital Status
12%
Polymerase Chain Reaction System
12%
Long Term Exposure
12%
Papillomavirus Infection
12%
Cesarean Section
12%
Infection Rate
12%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Human Papillomavirus
100%
Prevalence
100%
Human Papillomavirus Type 18
18%
Long Term Exposure
9%
Uterine Cervix Cancer
9%
Preeclampsia
9%
Infection Rate
9%
Papillomavirus Infection
9%
Human Papillomavirus Type 31
9%
Human Papillomavirus Type 16
9%
Human Papillomavirus Type 51
9%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Human Immunodeficiency Virus
100%
Wart Virus
100%
CD4 Lymphocyte Count
25%
Human Papillomavirus Type 18
16%
Genotyping
8%
Infection Rate
8%
Human Papillomavirus Type 16
8%
Human Papillomavirus Type 31
8%
Human Papillomavirus Type 51
8%
Immunology and Microbiology
Prevalence
100%
Human Immunodeficiency Virus
100%
Wart Virus
100%
CD4 Lymphocyte Count
25%
Human Papillomavirus Type 18
16%
Human Papillomavirus Type 31
8%
Human Papillomavirus Type 16
8%
Infection Rate
8%
Human Papillomavirus Type 51
8%